Menu
Recruiting NCT07129317

Pediatric Radiation Therapy Registry

Observational Sarcoma Pediatric Brain Tumors

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Sarcoma, Pediatric Brain Tumors. Basic parameters: 0 years — 26 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include all pediatric patients undergoing proton therapy and photon therapy to enable future comparisons of treatment outcomes.

Primary outcome measures

  • Overall Survival [Time frame: Approximately 10 years]
  • Toxicity due to Radiation Therapy as assessed by number of patients with adverse events [Time frame: Approximately 10 years]

Eligibility criteria

Inclusion criteria

  • Treatment with either proton or photon radiation therapy.

Exclusion criteria

  • Greater than 26 years old

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 2 centers
  • Sibley Memorial Hospital — Washington D.C.
  • Johns Hopkins Hospital — Baltimore

Identifiers

NCT: NCT07129317 · J2563 · IRB00504065

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗